Shuo Yuan

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect.

A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: July 20, 2026

A comprehensive review of the mechanism and application prospect of PARP dual-target inhibitors in tumor treatment.

A comprehensive review of the mechanism and application prospect of PARP dual-target inhibitors in tumor treatment.

Journal: European journal of medicinal chemistry

Published: June 16, 2026

HDA-YOLO: a hierarchical and densely-fused attention network for rice pest detection in complex agricultural environments.

HDA-YOLO: a hierarchical and densely-fused attention network for rice pest detection in complex agricultural environments.

Journal: Frontiers in plant science

Published: December 09, 2025

A Comprehensive Review of Marketed KRAS Inhibitors and Degraders: Challenges and Opportunities.

A Comprehensive Review of Marketed KRAS Inhibitors and Degraders: Challenges and Opportunities.

Journal: Medicinal research reviews

Published: June 12, 2025

The prospects and challenges of small molecule drugs in the treatment of Duchenne muscular dystrophy.

The prospects and challenges of small molecule drugs in the treatment of Duchenne muscular dystrophy.

Journal: European journal of medicinal chemistry

Published: June 09, 2025

The LSD1/HDAC dual-target inhibitor for cancer therapy: Challenge and opportunity.

The LSD1/HDAC dual-target inhibitor for cancer therapy: Challenge and opportunity.

Journal: Bioorganic chemistry

Published: June 05, 2025

Targeting undruggable protein KRAS for cancer therapy: novel opportunities and challenges.

Targeting undruggable protein KRAS for cancer therapy: novel opportunities and challenges.

Journal: Future medicinal chemistry

Published: December 23, 2024

Discovery of 1,2,4-Triazole-3-thione Derivatives as Potent and Selective DCN1 Inhibitors for Pathological Cardiac Fibrosis and Remodeling.

Discovery of 1,2,4-Triazole-3-thione Derivatives as Potent and Selective DCN1 Inhibitors for Pathological Cardiac Fibrosis and Remodeling.

Journal: Journal of medicinal chemistry

Published: August 19, 2024

A comprehensive review of new small molecule drugs approved by the FDA in 2022: Advance and prospect.

A comprehensive review of new small molecule drugs approved by the FDA in 2022: Advance and prospect.

Journal: European journal of medicinal chemistry

Published: July 16, 2024

The recent advance of PROTACs targeting BCR-ABL for the treatment of chronic myeloid leukemia.

The recent advance of PROTACs targeting BCR-ABL for the treatment of chronic myeloid leukemia.

Journal: Bioorganic chemistry

Published: June 06, 2024

A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects.

A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects.

Journal: European journal of medicinal chemistry

Published: June 03, 2024

Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as potent reversal agents against ABCB1-mediated multidrug resistance.

Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as potent reversal agents against ABCB1-mediated multidrug resistance.

Journal: European journal of medicinal chemistry

Published: May 25, 2024

Showing 1-12 of 37

Last Updated: 09/26/2026